NANO Nuclear Energy finds itself in an awkward middle ground: the squeeze that defined late May has partly unwound, availability has opened up, yet 19% of the float remains short and the stock has added another 5% this week.
The clearest change from the May 27 note is in the lending market. Availability has climbed to 15% — still tight by any normal measure, but a dramatic loosening from the near-zero readings that characterized the peak squeeze, when availability had collapsed below 2% for four consecutive sessions. That recovery in supply has coincided with short interest pulling back about 9% on the week to 19.3% of the free float, down from the 23.9% peak flagged in the previous note. Shorts are covering, incrementally, but the base is far from gone. Cost to borrow has also eased — running at 3.4%, roughly half the 6% level seen in late April — confirming that lender pricing has not re-escalated even as the stock grinds higher. The divergence between a still-substantial short base and a softening borrow market is the key tension: bears are paying less to stay in, which reduces the mechanical pressure to exit.
The ORTEX short score of 73.7 keeps NNE deep in high-conviction short territory, ranking in the 2nd percentile for short score rank across the universe. Days to cover sits at 3.3 per the latest FINRA data, meaning any accelerated covering would take multiple sessions to clear. Options positioning remains constructive for bulls: the put/call ratio is 0.47, modestly above its 20-day average of 0.44 but barely a standard deviation out, and well below the 52-week defensive high of 0.80. Options traders are not bracing for a reversal — call demand continues to dominate the order flow.
The Street picture is complicated by stale data. The most recent analyst action in the system dates to August 2025, so the formal consensus — two buys, mean target of $47.50 — should be treated with caution given how much has changed in the stock since then. At $30.57, the stock trades at a meaningful discount to that target, but the valuation story is pre-revenue: the P/E is deeply negative at -32.7, and EV/EBITDA is similarly uninformative at -25.5. Factor scores underline the speculative nature of the setup — EPS momentum ranks in the 10th percentile on a 30-day basis, and the forward EPS growth trajectory ranks near the bottom of the universe. The stock is priced on narrative and positioning, not on fundamentals.
On the institutional side, the largest holder — I Financial Ventures Group — trimmed its position in late January, selling over $9.5 million worth of shares across multiple tranches while still holding roughly 16.75% of outstanding shares. Mirae Asset added over a million shares in the most recent quarter, and Vanguard Capital Management initiated a fresh position of 1.65 million shares as of March 31. The institutional mix is therefore pulling in two directions: strategic holders trimming at elevated prices while passive and thematic funds continue to build.
The May earnings print is the one concrete post-event data point: the stock fell nearly 8% the day after results and shed another 7% over the subsequent five days. The next earnings event is scheduled for August 13 — still more than two months out — which means near-term direction will be driven almost entirely by positioning dynamics, sector sentiment around small modular reactor policy, and whether the partial squeeze relief holds or reverses. The watch point is whether availability stays in the 10-20% range or tightens back toward the near-zero readings that defined the May squeeze — the direction of that single metric will determine how much fuel remains for either side.
See the live data behind this article on ORTEX.
Open NNE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
